
Stemson Therapeutics: Pioneering pre-clinical cell therapy for safe, natural hair restoration.
Stemson Therapeutics, founded with a vision to address the emotional and social impacts of hair loss, is a pre-clinical cell therapy company dedicated to developing revolutionary treatments for natural hair restoration. Their core mission is to provide a safe and effective solution for individuals suffering from hair loss by creating new hair follicles through advanced cell therapy techniques. Stemson Therapeutics aims to transform the hair restoration market by offering a scientifically-grounded alternative to current treatments that do not generate new hair follicles.
Notable figures affiliated with Stemson Therapeutics include experts in the fields of regenerative medicine and biotechnology. The company has attracted significant interest from investors focused on innovative healthcare solutions. Key achievements include advancing their cell therapy technology through pre-clinical stages and establishing a strong foundation for future clinical trials. Stemson Therapeutics has made a substantial impact by pushing the boundaries of hair restoration science, promising a potential breakthrough for millions affected by hair loss globally.
Companies similar to Stemson Therapeutics include APstem Therapeutics, Amplifica, Stemedica Cell Technologies and Cellebration Life Sciences.
Stemson Therapeutics was founded in 2018.
Stemson Therapeutics' headquarters is located in San Diego, CA, US.
Stemson Therapeutics' most recent funding round was for $15M (USD) in July 2021.
As of Jul 15, 2021, Stemson Therapeutics has disclosed funding of $22.5M (USD). Undisclosed round amounts are excluded.
Stemson Therapeutics has 36 employees as of Feb 4, 2024.
Cellebration Life Sciences